Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GLS | O94925 | 1/20 | 0.38 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9038869 | 0.79 | POLB (0.58) | HRH4HRH3ALDH1A1 | |
| SCHEMBL10842673 | 0.73 | MAPT (0.45) | HRH4HRH3ALDH1A1MAPTPKM | |
| SCHEMBL10841460 | 0.73 | L3MBTL1 (0.48) | HRH4HRH3MAPTHPGDLMNA | |
| SCHEMBL9039325 | 0.72 | ALDH1A1 (0.50) | HRH4HRH3CYP1A2ALDH1A1FGFR1 | |
| SCHEMBL23577365 | 0.71 | HRH4 (0.43) | HRH4HRH3ALDH1A1FGFR1MAPT | |
| SCHEMBL30013724 | 0.71 | HRH4 (0.43) | HRH4HRH3ALDH1A1FGFR1MAPT | |
| SCHEMBL30979120 | 0.71 | HRH4 (0.46) | HRH4HRH3ALDH1A1FGFR1MAPT | |
| SCHEMBL19036234 | 0.70 | HRH4 (0.42) | HRH4HRH3TSHR | |
| SCHEMBL19036207 | 0.70 | GRIN2D (0.41) | HPGDLMNA | |
| SCHEMBL23576679 | 0.70 | PARP1 (0.46) | HRH4HRH3CYP1A2FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9859506-B2 | Organic electroluminescent compound and organic photoelectric apparatus thereof | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2018-01-02 | — | — | US | disclosed |
| US-20170186972-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS THEREOF | Shanghai Tianma AM-OLED Co., Ltd. | 2017-06-29 | — | — | US | disclosed |
| US-20170186972-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS THEREOF | Shanghai Tianma AM-OLED Co., Ltd. | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170186972-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC PHOTOELECTRIC APPARATUS THEREOF | CCNL2, C1S, CCNE2 | HRH4 926/4885HRH3 815/4885CYP1A2 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.